Dr. Troy Quigg, DO
Claim this profileHelen DeVos Children's Hospital
Studies Metabolic disorders
Studies Severe Combined Immunodeficiency
11 reported clinical trials
30 drugs studied
Area of expertise
1Metabolic Disorders
Hemoglobin S positive
Hemoglobin S negative
2Severe Combined Immunodeficiency
HLA positive
CD62L negative
CD45RO positive
Affiliated Hospitals
Clinical Trials Troy Quigg, DO is currently running
Non-TBI Conditioning
for HCT in Acute Lymphoblastic Leukemia
This study will evaluate the use of non- TBI (total body irradiation) conditioning for B-ALL patients with low risk of relapse as defined by absence of NGS-MRD (next generation sequencing minimal residual disease) before receiving a hematopoietic cell transplant (HCT). Patients diagnosed with B-ALL who are candidates for HCT will be screened by NGS-MRD on a test of bone marrow done before the HCT. Subjects who are pre-HCT NGS-MRD negative will be eligible to receive a non-TBI conditioning regimen as part of the treatment cohort of the study. Subjects who are pre-HCT NGS-MRD positive will be treated as per treating center standard and will be followed in an observational cohort (HCT center standard of care).
Recruiting1 award Phase 2
RIC + BMT
for Non-Malignant Disorders
This study is designed to estimate the efficacy and toxicity of familial HLA mismatched bone marrow transplants in patients with non-malignant disease who are less than 21 years of age and could benefit from the procedure.
Recruiting1 award Phase 1 & 220 criteria
More about Troy Quigg, DO
Clinical Trial Related7 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Troy Quigg, DO has experience with
- Fludarabine
- Melphalan
- Busulfan
- Cyclophosphamide
- Methotrexate
- Alemtuzumab
Breakdown of trials Troy Quigg, DO has run
Metabolic disorders
Severe Combined Immunodeficiency
Immune Dysfunction
Acute Lymphoblastic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Troy Quigg, DO specialize in?
Troy Quigg, DO focuses on Metabolic disorders and Severe Combined Immunodeficiency. In particular, much of their work with Metabolic disorders has involved Hemoglobin S positive patients, or patients who are Hemoglobin S negative.
Is Troy Quigg, DO currently recruiting for clinical trials?
Yes, Troy Quigg, DO is currently recruiting for 7 clinical trials in Grand Rapids Michigan. If you're interested in participating, you should apply.
Are there any treatments that Troy Quigg, DO has studied deeply?
Yes, Troy Quigg, DO has studied treatments such as Fludarabine, Melphalan, Busulfan.
What is the best way to schedule an appointment with Troy Quigg, DO?
Apply for one of the trials that Troy Quigg, DO is conducting.
What is the office address of Troy Quigg, DO?
The office of Troy Quigg, DO is located at: Helen DeVos Children's Hospital, Grand Rapids, Michigan 49503 United States. This is the address for their practice at the Helen DeVos Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.